760346

544647

NEPHROPLUS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Nephrocare Health Serv L Share Price Today

NEPHROCARE HEALTH SERV L is currently trading at ₹723.35, down by ₹13.65 from the previous close. During the latest trading session, the stock touched an intraday high of ₹745.85 and a low of ₹713.20. Over the past six months, NEPHROCARE HEALTH SERV L has delivered a return of 0.0%, while the stock has gained 14.48% in the last one month.

Nephrocare Health Serv L performance

Today’s low Today’s high
₹ 713.20 ₹ 745.85
₹ 723.35
52 week low 52 week high
₹ 446.00 ₹ 769.75
₹ 723.35
Open Price ₹ 732.00
Prev. Close ₹ 737.00
Volume (Shares) 261481.00
Total traded value ₹ 1891.42
Upper Circuit ₹ 884.40
Lower Circuit ₹ 589.60
info

Investment Returns

Over 1 Month 14.48% Over 3 Months 43.03% Over 6 Months 56.39% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Nephrocare Health Serv L fundamentals


  • Market cap (Cr) 7,258.10
  • P/E Ratio (TTM) 0.00
  • Beta 0.74
  • Book Value / share 90.58
  • Return on equity 6.02%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 10.89
info icon alternate text
  • Market cap (Cr) 7,253.10
  • P/E Ratio (TTM) 0.00
  • Beta 0.74
  • Book Value / share 90.58
  • Return on equity 6.02%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 10.89
info icon alternate text

Nephrocare Health Serv L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 164.33
Operating Expense 159.47
Net Profit 10.89
Net Profit Margin (%) 6.62
Earnings Per Share (EPS) 1.09
EBITDA 28.21
Effective Tax Rate (%) 1.00
Particulars DEC 2025 (Values in Cr)
Revenue 160.66
Operating Expense 155.17
Net Profit 8.45
Net Profit Margin (%) 5.25
Earnings Per Share (EPS) 0.90
EBITDA 26.33
Effective Tax Rate (%) 5.69
Particulars SEP 2025 (Values in Cr)
Revenue 155.92
Operating Expense 189.41
Net Profit -32.41
Net Profit Margin (%) -20.78
Earnings Per Share (EPS) -3.82
EBITDA 26.33
Effective Tax Rate (%) -5.87
Particulars JUN 2025 (Values in Cr)
Revenue 148.83
Operating Expense 0.00
Net Profit 5.01
Net Profit Margin (%) 3.36
Earnings Per Share (EPS) 0.50
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 145.01
Operating Expense 140.33
Net Profit 5.67
Net Profit Margin (%) 3.91
Earnings Per Share (EPS) 0.70
EBITDA 24.49
Effective Tax Rate (%) 23.45
Particulars MAR 2026 (Values in Cr)
Revenue 629.74
Operating Expense 648.95
Net Profit -8.06
Net Profit Margin (%) -1.27
Earnings Per Share (EPS) -0.89
EBITDA 103.60
Effective Tax Rate (%) -113.79
Particulars MAR 2025 (Values in Cr)
Revenue 543.60
Operating Expense 513.87
Net Profit 34.24
Net Profit Margin (%) 6.29
Earnings Per Share (EPS) 4.23
EBITDA 110.52
Effective Tax Rate (%) 24.51
Particulars MAR 2025 (Values in Cr)
Book Value / Share 3288.65
ROE % 12.00
ROCE % 13.01
Total Debt to Total Equity 0.53
EBITDA Margin 23.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 2345.99
ROE % 7.87
ROCE % 7.66
Total Debt to Total Equity 0.58
EBITDA Margin 19.33
Particulars MAR 2023 (Values in Cr)
Book Value / Share 2213.96
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.40
EBITDA Margin 12.48
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2254.31
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin 8.08
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1546.19
ROE % 0.18
ROCE % 1.73
Total Debt to Total Equity 0.55
EBITDA Margin 14.75
Particulars MAR 2025 (Values in Cr)
Book Value / Share 3051.81
ROE % 6.02
ROCE % 8.11
Total Debt to Total Equity 0.32
EBITDA Margin 20.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 2291.71
ROE % 0.87
ROCE % 2.60
Total Debt to Total Equity 0.47
EBITDA Margin 13.72
Particulars MAR 2023 (Values in Cr)
Book Value / Share 2260.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin 11.15
Particulars MAR 2022 (Values in Cr)
Book Value / Share 2346.99
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.38
EBITDA Margin 6.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1550.56
ROE % 0.30
ROCE % 1.81
Total Debt to Total Equity 0.55
EBITDA Margin 14.93
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 155.38
Total Assets 996.46
Total Liabilities 996.46
Total Equity 584.11
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.73
Return on Capital (%) 8.28
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 61.17
Total Assets 806.01
Total Liabilities 806.01
Total Equity 413.70
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.35
Return on Capital (%) 5.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 127.30
Total Assets 666.23
Total Liabilities 666.23
Total Equity 388.63
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -1.76
Return on Capital (%) -2.02
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 143.36
Total Assets 570.64
Total Liabilities 570.64
Total Equity 395.99
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -3.73
Return on Capital (%) -4.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 64.58
Total Assets 428.06
Total Liabilities 428.06
Total Equity 259.31
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.14
Return on Capital (%) 0.15
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 33.42
Total Assets 756.61
Total Liabilities 756.61
Total Equity 542.00
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 4.52
Return on Capital (%) 5.15
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.64
Total Assets 664.57
Total Liabilities 664.57
Total Equity 404.21
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.58
Return on Capital (%) 0.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.22
Total Assets 646.89
Total Liabilities 646.89
Total Equity 396.64
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -2.39
Return on Capital (%) -2.61
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 128.06
Total Assets 571.90
Total Liabilities 571.90
Total Equity 411.99
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -3.84
Return on Capital (%) -4.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 63.52
Total Assets 418.78
Total Liabilities 418.78
Total Equity 250.13
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.23
Return on Capital (%) 0.26
Particulars MAR 2025 (Values in Cr)
Net Income 87.43
Cash from Operations 136.30
Cash from Investing -125.07
Cash from Financing 54.37
Net change in Cash 64.64
Free Cash Flow 236.07
Particulars MAR 2024 (Values in Cr)
Net Income 33.16
Cash from Operations 80.34
Cash from Investing -50.66
Cash from Financing 26.73
Net change in Cash 48.35
Free Cash Flow 157.69
Particulars MAR 2023 (Values in Cr)
Net Income -8.59
Cash from Operations 6.64
Cash from Investing -78.20
Cash from Financing 59.96
Net change in Cash -4.49
Free Cash Flow 78.21
Particulars MAR 2022 (Values in Cr)
Net Income -27.14
Cash from Operations 19.12
Cash from Investing -129.29
Cash from Financing 121.29
Net change in Cash 6.03
Free Cash Flow 97.47
Particulars MAR 2021 (Values in Cr)
Net Income 0.89
Cash from Operations 18.20
Cash from Investing -61.35
Cash from Financing 35.79
Net change in Cash 5.26
Free Cash Flow 67.87
Particulars MAR 2025 (Values in Cr)
Net Income 45.36
Cash from Operations 74.34
Cash from Investing -103.51
Cash from Financing 26.02
Net change in Cash 2.23
Free Cash Flow 154.10
Particulars MAR 2024 (Values in Cr)
Net Income 0.21
Cash from Operations 59.14
Cash from Investing -19.25
Cash from Financing -35.54
Net change in Cash -1.46
Free Cash Flow 131.00
Particulars MAR 2023 (Values in Cr)
Net Income -12.87
Cash from Operations 7.19
Cash from Investing -74.70
Cash from Financing 63.38
Net change in Cash -0.17
Free Cash Flow 43.97
Particulars MAR 2022 (Values in Cr)
Net Income -28.07
Cash from Operations 16.71
Cash from Investing -167.48
Cash from Financing 147.37
Net change in Cash -8.19
Free Cash Flow 59.68
Particulars MAR 2021 (Values in Cr)
Net Income 1.28
Cash from Operations 19.21
Cash from Investing -64.15
Cash from Financing 35.80
Net change in Cash 4.20
Free Cash Flow 69.75
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8432.15 61.98 12.79 121241.38 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 53.09 24.02 2.89 99.50 40.75 76.00
SHREE PACETRONIX LTD. 138.30 16.50 2.91 51.86 66.10 283.15
TRANSGENE BIOTEK LTD. 2.96 0.00 2.67 22.43 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8432.15 80.76 12.16 121241.38 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 37.42 0.00 -9.10 27.95 30.30 57.48
KOVAI MEDICAL CENTER & HO 5844.00 26.15 4.84 6393.34 5010.00 6725.00

Nephrocare Health Serv L shareholding pattern

Holding
17.56%
63.85%
9.93%
8.64%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Nephrocare Health Serv L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
723.35 -1.85 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 730.80
  • 26 Days 663.40
  • 10 Days 712.30
  • 50 Days 623.50
  • 12 Days 704.70
  • 100 Days 581.40
  • 20 Days 678.60
  • 200 Days 556.20
734.88 PIVOT
First Support 722.77 First Resistance 749.12 Second Support 708.53 Second Resistance 761.23 Third Support 696.42 Third Resistance 775.47
RSI 67.22 ADX 52.24 MACD 41.34 Williams % R -18.85 Commodity Channel Index (CCI) 99.69
Date 2026-06-17 Week 88651.00 Same Day 50131.00 Month 128541.00
1 Year 0.74 3 Year 0.73
Over 1 Month
14.48% down
Over 1 Year
0.00% down
Over 3 Months
43.03% down
Over 3 Years
0.00% down
Over 6 Months
56.39% down
Over 5 Years
0.00% down

Nephrocare Health Serv L Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Nephrocare Health Services Ltd?

Answer Field

Nephrocare Health Services Ltd share price is for NSE ₹ 723.35 & for BSE ₹ 722.85 as on Jun 18 2026 03:30 PM.

What is the Market Cap of Nephrocare Health Services Ltd Share?

Answer Field

The market cap of Nephrocare Health Services Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 18 2026 03:30 PM.

What is the 52 Week High and Low of Nephrocare Health Services Ltd?

Answer Field

The 52 Week High and Low of Nephrocare Health Services Ltd for NSE is ₹ 769.75 and ₹ 446.00 and for BSE is ₹ 767.95 and ₹ 445.00.

What is 1 year return for Nephrocare Health Services Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Nephrocare Health Services Ltd Share?

Answer Field

As on Jun 18 2026 03:30 PM the price-to-earnings (PE) ratio for Nephrocare Health Services Ltd share is 0.00.

What is the PB ratio of Nephrocare Health Services Ltd Share?

Answer Field

As on Jun 18 2026 03:30 PM, the price-to-book (PB) ratio for Nephrocare Health Services Ltd share is 90.58.

How to Buy Nephrocare Health Services Ltd Share?

Answer Field

You can trade in Nephrocare Health Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Nephrocare Health Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Nephrocare Health Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Nephrocare Health Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|